It's possible that we could get our prescriptions from a free-standing kiosk in a pharmacy or a grocery store (or elsewhere) in the future. At least, that's what Walgreen (NASDAQ:WBA) invested in when it put money behind MedAvail, a company whose website claims that "just as the ATM transformed the retail banking experience, MedAvail is transforming the prescription fulfillment experience."
This exciting technology could help consumers avoid long lines and restrictive pharmacy hours. The function is simple: Someone could fill a prescription by simply going to a small kiosk, feeding in their prescription information, and then video-chatting with a pharmacist before paying and immediately receiving their medicine.
This technology offers some notable benefits for the consumer: Speed, personalization (the short consult with the pharmacist), and convenience. Of course, the opportunities for companies looking to place the kiosks are manifold too. According to a MedAvail presentation, the upfront expense of one of these kiosks is $100,000 versus $1.5 million or more for a full-service retail pharmacy. And with lower staffing requirements and a small real estate footprint, there are even more exciting opportunities with this disruptive technology.
In the video below, from Market Checkup, the Motley Fool's health care-focused investing show, health care analysts Michael Douglass and David Williamson lay out the opportunities for this interesting startup and the potential to dramatically change how pharmacies work.
If you think MedAvail's big, check this out!
Apple recently recruited a secret-development "dream team" to guarantee its newest smart device was kept hidden from the public for as long as possible. But the secret is out, and some early viewers are claiming its everyday impact could trump the iPod, iPhone, and the iPad. In fact, ABI Research predicts 485 million of this type of device will be sold per year. But one small company makes Apple's gadget possible. And its stock price has nearly unlimited room to run for early in-the-know investors. To be one of them, and see Apple's newest smart gizmo, just click here!
David Williamson and Michael Douglass own shares of Apple. The Motley Fool recommends and owns shares of Apple. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.